Zanubrutinib
Update Venetoclax in CLL
Acalabrutinib
(Update) Acalabrutinib in CLL and MCL
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
Patient Power
CLL Society
UpToDate